Robert L Erwin
CIK 1213822 · View on SEC EDGAR ↗
First SEC filing: July 26, 2012 · Latest: July 26, 2012
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 15, 2013 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| July 24, 2012 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Oct. 21, 2011 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 16, 2010 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 10, 2009 | IBIO | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 13, 2009 | IBIO | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 15, 2013 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $0.52 | July 15, 2023 | 300,000 | Acquired |
| July 24, 2012 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.10 | July 24, 2022 | 300,000 | Acquired |
| Oct. 21, 2011 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.96 | Oct. 21, 2021 | 300,000 | Acquired |
| Aug. 16, 2010 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.73 | Aug. 16, 2020 | 300,000 | Acquired |
| Aug. 10, 2009 | IBIO | Stock Option (right to buy) | Common Stock (250,000) | $0.66 | Aug. 10, 2019 | 250,000 | Acquired |
| Feb. 13, 2009 | IBIO | Stock Option (right to buy) | Common Stock (250,000) | $0.20 | Feb. 13, 2019 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $275,000 | — | — | — | — | — | $16,751 | $291,751 |
| 2018 | — | — | — | — | — | — | — | — |
| 2017 | $230,000 | — | — | $107,085 | — | — | — | $337,085 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.